Free Trial

Oppenheimer's Rating of (YONG) on 12/9/2010

On December 9, 2010, Oppenheimer updated its outlook on (YONG) (NASDAQ:YONG) with the action "Downgrade", setting a "Outperform�- Perform" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Oppenheimer Holdings, Inc.

DateCompanyAction
10/10/2025
Marvell Technology, Inc. stock logo
MRVL
Marvell Technology
Set Price Target
10/10/2025
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
Set Price Target
10/10/2025
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
Set Price Target
10/10/2025
Guardian Pharmacy Services, Inc. stock logo
GRDN
Guardian Pharmacy Services
Set Price Target
10/9/2025
Sunrun Inc. stock logo
RUN
Sunrun
Boost Price Target
10/9/2025
Enphase Energy, Inc. stock logo
ENPH
Enphase Energy
Lower Price Target
More Ratings From Oppenheimer Holdings, Inc.